Teladoc Health Research and Development Expenses 2014-2023 | TDOC
Teladoc Health research and development expenses from 2014 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Teladoc Health Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $349 |
| 2022 | $334 |
| 2021 | $312 |
| 2020 | $165 |
| 2019 | $65 |
| 2018 | $54 |
| 2017 | $34 |
| 2016 | $22 |
| 2015 | $14 |
| 2014 | $8 |
| 2013 | $4 |
| Teladoc Health Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023-12-31 | $90 |
| 2023-09-30 | $84 |
| 2023-06-30 | $87 |
| 2023-03-31 | $87 |
| 2022-12-31 | $83 |
| 2022-09-30 | $85 |
| 2022-06-30 | $79 |
| 2022-03-31 | $87 |
| 2021-12-31 | $73 |
| 2021-09-30 | $80 |
| 2021-06-30 | $81 |
| 2021-03-31 | $78 |
| 2020-12-31 | $93 |
| 2020-09-30 | $30 |
| 2020-06-30 | $23 |
| 2020-03-31 | $19 |
| 2019-12-31 | $16 |
| 2019-09-30 | $16 |
| 2019-06-30 | $17 |
| 2019-03-31 | $16 |
| 2018-12-31 | $14 |
| 2018-09-30 | $14 |
| 2018-06-30 | $14 |
| 2018-03-31 | $13 |
| 2017-12-31 | $10 |
| 2017-09-30 | $10 |
| 2017-06-30 | $8 |
| 2017-03-31 | $7 |
| 2016-12-31 | $6 |
| 2016-09-30 | $6 |
| 2016-06-30 | $5 |
| 2016-03-31 | $5 |
| 2015-12-31 | $4 |
| 2015-09-30 | $4 |
| 2015-06-30 | $3 |
| 2015-03-31 | $3 |
| 2014-12-31 | $2 |
| 2014-09-30 | $2 |
| 2014-06-30 | $2 |
| 2014-03-31 | $1 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.188B | $2.602B |
| Teladoc Health, Inc. provides virtual access to high-quality care and expertise with a portfolio of services and solutions, covering medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company combines the latest in data and analytics with an award-winning user experience through a highly flexible technology platform. The company provides access to healthcare through its portfolio of five consumer brands 24 hours a day, seven days a week and 365 days a year. Its solutions are delivered with an approximate median response time of less than ten minutes in the United States for general medical inquiries from the time a member requests a general medical telehealth visit to the time they consult with a Teladoc Health network provider. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $126.410B | 15.86 |
| Cencora (COR) | United States | $44.248B | 17.25 |
| ICON (ICLR) | Ireland | $26.054B | 24.60 |
| DiDi Global (DIDIY) | China | $22.390B | 0.00 |
| Avantor (AVTR) | United States | $16.968B | 24.98 |
| CochLear (CHEOY) | Australia | $14.783B | 0.00 |
| Revvity (RVTY) | United States | $13.383B | 23.48 |
| Natera (NTRA) | United States | $13.324B | 0.00 |
| Viatris (VTRS) | United States | $13.121B | 3.92 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.374B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.185B | 40.09 |
| Charles River Laboratories (CRL) | United States | $11.577B | 22.17 |
| Solventum (SOLV) | United States | $10.632B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.628B | 0.00 |
| HealthEquity (HQY) | United States | $6.727B | 50.26 |
| Organon (OGN) | United States | $5.534B | 5.25 |
| Bausch + Lomb (BLCO) | Canada | $5.357B | 21.47 |
| Doximity (DOCS) | United States | $4.429B | 30.83 |
| PACS (PACS) | United States | $4.249B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.362B | 30.76 |
| Sotera Health (SHC) | United States | $3.230B | 15.85 |
| Life Times (LTH) | United States | $3.106B | 32.54 |
| GoodRx Holdings (GDRX) | United States | $3.024B | 115.14 |
| Progyny (PGNY) | United States | $2.623B | 45.16 |
| NovoCure (NVCR) | Jersey | $2.386B | 0.00 |
| Agilon Health (AGL) | United States | $2.295B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.244B | 8.89 |
| Premier (PINC) | United States | $2.073B | 8.87 |
| BrightSpring Health Services (BTSG) | United States | $1.953B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.595B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.336B | 0.00 |
| Embecta (EMBC) | United States | $0.819B | 5.57 |
| CareDx (CDNA) | United States | $0.770B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Pediatrix Medical (MD) | United States | $0.656B | 6.96 |
| Auna S.A (AUNA) | Luxembourg | $0.632B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.627B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.546B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.519B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| Enhabit (EHAB) | United States | $0.419B | 41.75 |
| ModivCare (MODV) | United States | $0.396B | 7.41 |
| MultiPlan (MPLN) | United States | $0.385B | 0.00 |
| Beauty Health (SKIN) | United States | $0.342B | 0.00 |
| LifeMD (LFMD) | United States | $0.326B | 0.00 |
| DocGo (DCGO) | United States | $0.325B | 17.78 |
| Ascend Wellness Holdings (AAWH) | United States | $0.289B | 0.00 |
| Sharecare (SHCR) | United States | $0.284B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.274B | 0.00 |
| Biodesix (BDSX) | United States | $0.179B | 0.00 |
| So-Young (SY) | China | $0.123B | 41.33 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 6.80 |
| Oncology Institute (TOI) | United States | $0.050B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| Nutex Health (NUTX) | United States | $0.037B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.027B | 0.00 |
| OncoCyte (OCX) | United States | $0.025B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |